STING Membrane Prevents Post‐Surgery Tissue Adhesion and Tumor Recurrence of Colorectal Cancer
Advanced Materials · 2024
DOI: 10.1002/adma.202309655 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Jianlin Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: The State Key Laboratory of Organic-inorganic Composites, Beijing Laboratory of Biomedical Materials, Key Laboratory of Biomedical Materials of Natur…. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Membrane Proteins, Neoplasm Recurrence, Local, Xanthones. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Funds on Biomedical Translation of China-Japan Friendship Hospital, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Surgery is the standard treatment regimen for resectable colorectal cancer (CRC). However, it is very hard to completely remove all cancer cells in clinical practice, leading to the high recurrence rates of the disease. Moreover, the post‐surgery tissue adhesion greatly prevents the possibility of reoperation, significantly limiting the long‐term surviving of CRC patients. To overcome CRC recurrence and avoid the post‐surgery tissue adhesion, this work develops a novel stimulator of interferon genes “STING” membrane based on the coaxial electrospinning technology and hyaluronic acid modification. A reactive oxygen species responsive prodrug of gambogic acid (GB) and a potent STING agonist (CDN) are coloaded in the core–shell structure of the membrane, which endows the loaded drug with sustained and sequential release patterns. The localized delivery of GB and CDN can selectively induce efficient immunogenic cell death of cancer cells and then evoke the systemic anticancer immunity by activating the Cyclic GMP‐AMP (cGAMP) synthase/STING pathway. As‐designed “STING” membrane not only safely prevents tumor recurrence through the synergistic chemoimmunotherapy but also efficiently avoids the post‐surgery tissue adhesion, facilitating the clinical intervention of CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The State Key Laboratory of Organic-inorganic Composites, Beijing Laboratory of Biomedical Materials, Key Laboratory of Biomedical Materials of Natural Macromolecules (Ministry of Education), College of Life Science and…
- Department of Urology, China-Japan Friendship Hospitals, Beijing, 100029, China.
ORCID-Profile: Qingsong Yu
Förderung
- National Natural Science Foundation of China
- Research Funds on Biomedical Translation of China-Japan Friendship Hospital
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Li, J., Yu, H., Kang, Y., Niu, K., Wang, M., Jiang, Y., Jiang, N., Ding, Z., Gan, Z., & Yu, Q. (2024). STING Membrane Prevents Post‐Surgery Tissue Adhesion and Tumor Recurrence of Colorectal Cancer. Advanced Materials. https://doi.org/10.1002/adma.202309655
Vancouver
Li J, Yu H, Kang Y, Niu K, Wang M, Jiang Y, et al. STING Membrane Prevents Post‐Surgery Tissue Adhesion and Tumor Recurrence of Colorectal Cancer. Advanced Materials. 2024. doi:10.1002/adma.202309655
BibTeX
@article{Li2024,
author = {Li, Jianlin and Yu, Haiwang and Kang, Yan and Niu, Kun and Wang, Ming and Jiang, Yitong and Jiang, Ni and Ding, Zhenshan and Gan, Zhihua and Yu, Qingsong},
title = {STING Membrane Prevents Post‐Surgery Tissue Adhesion and Tumor Recurrence of Colorectal Cancer},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202309655}
}
EUVIMED